Posted by Michael Wonder on 06 Jan 2020
Generic makers will appeal ruling that allows California to proceed with law banning pay-to-delay deals
3 January 2020 - A federal judge dealt the pharmaceutical industry a setback by declining to block a new California law that bans so-called pay-to-delay deals between drug makers, prompting an industry trade group to pursue an appeal with a higher court.
The move comes after the Association for Accessible Medicines filed a lawsuit two months ago to thwart the state law, which was the first in the nation to outlaw pay-to-delay deals.
California officials explained the step was necessary in order to prevent drug companies from thwarting competition and maintaining higher prices for medicines.
